These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12707934)

  • 21. Homozygosity at the dopamine D3 receptor gene in schizophrenic patients.
    Durany N; Thome J; Palomo A; Foley P; Riederer P; Cruz-Sánchez FF
    Neurosci Lett; 1996 Dec; 220(3):151-4. PubMed ID: 8994215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia.
    Glatt SJ; Faraone SV; Tsuang MT
    Mol Psychiatry; 2003 Nov; 8(11):911-5. PubMed ID: 14593428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia.
    Li T; Arranz M; Aitchison KJ; Bryant C; Liu X; Kerwin RW; Murray R; Sham P; Collier DA
    Schizophr Res; 1998 Jul; 32(2):87-92. PubMed ID: 9713903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
    Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse.
    Goldman D; Urbanek M; Guenther D; Robin R; Long JC
    Alcohol; 1998 Jul; 16(1):47-52. PubMed ID: 9650635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An association study of dopaminergic (DRD2) and serotoninergic (5-HT2) gene polymorphism and schizophrenia in a North Indian population.
    Kaur G; Singh Chavan B; Gupta D; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J
    Asian J Psychiatr; 2019 Jan; 39():178-184. PubMed ID: 30389402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association between polymorphisms in the promoter region of dopamine receptor D2 gene and schizophrenia in the northern Chinese Han population: A case-control study.
    Zhang XC; Ding M; Adnan A; Liu Y; Liu YP; Xing JX; Xuan JF; Xia X; Yao J; Wang BJ
    Brain Behav; 2019 Feb; 9(2):e01193. PubMed ID: 30657260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DRD2 -141C insertion/deletion polymorphism is not associated with schizophrenia: results of a meta-analysis.
    Glatt SJ; Faraone SV; Tsuang MT
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):21-3. PubMed ID: 15211624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia.
    Crawford F; Hoyne J; Cai X; Osborne A; Poston D; Zaglul J; Dajani N; Walsh S; Bradley R; Solomon R; Mullan M
    Am J Med Genet; 1996 Sep; 67(5):483-4. PubMed ID: 8886166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The Cys allele of the DRD2 (Ser311Cys polymorphism) is associated with schizophrenia and worse sustained attention in patients].
    Golimbet VE; Lebedeva IS; Monakhov MV; Korovaĭtseva GI; Lezheĭko TV; Abramova LI; Kaleda VG; Karpov VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):67-70. PubMed ID: 19770837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D2 receptor gene -141C Insertion/Deletion polymorphism in Turkish schizophrenic patients.
    Kurt H; Dikmen M; Basaran A; Yenilmez C; Ozdemir F; Degirmenci I; Gunes HV; Kucuk MU; Mutlu F
    Mol Biol Rep; 2011 Feb; 38(2):1407-11. PubMed ID: 20665240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No association between a promoter dopamine D(4) receptor gene variant and schizophrenia.
    Jönsson EG; Ivo R; Forslund K; Mattila-Evenden M; Rylander G; Cichon S; Propping P; Nöthen MM; Asberg M; Sedvall GC
    Am J Med Genet; 2001 Aug; 105(6):525-8. PubMed ID: 11496369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
    J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia.
    Hattori M; Nanko S; Dai XY; Fukuda R; Kazamatsuri H
    Biochem Biophys Res Commun; 1994 Jul; 202(2):757-63. PubMed ID: 7914079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis.
    Liu L; Fan D; Ding N; Hu Y; Cai G; Wang L; Xin L; Xia Q; Li X; Xu S; Xu J; Yang X; Zou Y; Pan F
    Neurosci Lett; 2014 Nov; 583():43-8. PubMed ID: 25240594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes.
    Dubertret C; Bardel C; Ramoz N; Martin PM; Deybach JC; Adès J; Gorwood P; Gouya L
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):492-9. PubMed ID: 20138949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.
    Hori H; Ohmori O; Shinkai T; Kojima H; Nakamura J
    Am J Med Genet; 2001 Dec; 105(8):774-8. PubMed ID: 11803529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population.
    Behravan J; Hemayatkar M; Toufani H; Abdollahian E
    Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia.
    Serretti A; Macciardi F; Smeraldi E
    Schizophr Res; 1998 Nov; 34(3):207-10. PubMed ID: 9850987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity.
    Kotler M; Barak P; Cohen H; Averbuch IE; Grinshpoon A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Dec; 88(6):628-33. PubMed ID: 10581481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.